Net Cash Provided by (Used in) Operating Activities in USD of NEKTAR THERAPEUTICS from Q1 2010 to Q1 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
NEKTAR THERAPEUTICS quarterly/annual Net Cash Provided by (Used in) Operating Activities history and change rate from Q1 2010 to Q1 2025.
- NEKTAR THERAPEUTICS Net Cash Provided by (Used in) Operating Activities for the quarter ending 31 Mar 2025 was -$49.1M, a 2.43% decline year-over-year.
- NEKTAR THERAPEUTICS annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$176M, a 8.77% increase from 2023.
- NEKTAR THERAPEUTICS annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$193M, a 36.6% increase from 2022.
- NEKTAR THERAPEUTICS annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$304M, a 26.3% increase from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)